Andreas Reiter

1995–2025 年に発表

180
論文数
23,904
被引用数
85
h 指数
160
i10 指数

被引用数

Andreas Reiter の年別被引用数1979 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 5 件1997 年: 被引用 6 件1998 年: 被引用 18 件1999 年: 被引用 32 件2000 年: 被引用 39 件2001 年: 被引用 38 件2002 年: 被引用 52 件2003 年: 被引用 61 件2004 年: 被引用 38 件2005 年: 被引用 83 件2006 年: 被引用 79 件2007 年: 被引用 77 件2008 年: 被引用 67 件2009 年: 被引用 83 件2010 年: 被引用 107 件2011 年: 被引用 149 件2012 年: 被引用 163 件2013 年: 被引用 151 件2014 年: 被引用 165 件2015 年: 被引用 159 件2016 年: 被引用 181 件2017 年: 被引用 168 件2018 年: 被引用 112 件2019 年: 被引用 466 件2020 年: 被引用 586 件2021 年: 被引用 648 件2022 年: 被引用 765 件2023 年: 被引用 592 件2024 年: 被引用 958 件2025 年: 被引用 373 件2026 年: 被引用 6 件1980〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,886 件、この内訳の 24%ドイツ: 引用元論文 760 件、この内訳の 9.7%イタリア: 引用元論文 679 件、この内訳の 8.6%イギリス: 引用元論文 561 件、この内訳の 7.1%フランス: 引用元論文 452 件、この内訳の 5.8%スペイン: 引用元論文 310 件、この内訳の 3.9%中国: 引用元論文 284 件、この内訳の 3.6%オーストリア: 引用元論文 255 件、この内訳の 3.2%オランダ: 引用元論文 216 件、この内訳の 2.8%スイス: 引用元論文 209 件、この内訳の 2.7%カナダ: 引用元論文 202 件、この内訳の 2.6%スウェーデン: 引用元論文 184 件、この内訳の 2.3%
0%24%その他 23.7%

分野

  • Medicine69.7%
  • Biochemistry, Genetics and Molecular Biology14.2%
  • Immunology and Microbiology10.3%
  • Computer Science3.6%
  • Engineering0.8%
  • Social Sciences0.3%
  • その他1.1%

トピック

  • Acute Myeloid Leukemia Research12%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment10.1%
  • Eosinophilic Disorders and Syndromes6.5%
  • Chronic Myeloid Leukemia Treatments6.3%
  • Mast cells and histamine3.6%
  • Kruppel-like factors research3.2%
  • その他58.3%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  3. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Triggiani, Hanneke C. Kluin‐Nelemans, Stephen J. Galli, Lawrence B. Schwartz, Andreas Reiter, Alberto Órfão, Jason Gotlib, Michel Arock, Hans‐Peter Horny, Dean D. Metcalfe - HemaSphere 2021 被引用: 295

  4. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    著者: , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2018 被引用: 552

  5. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , - Allergy 2022 被引用: 157

  6. Mutations and prognosis in primary myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas C.P. Cross, Ayalew Tefferi - Leukemia 2013 被引用: 746

  7. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francisco Cervantes, Peter Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Björn Andréasson, Maria L Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegård, Ayalew Tefferi, Ruben A. Mesa - Journal of Clinical Oncology 2012 被引用: 458

  8. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Theranostics 2020 被引用: 182

  9. Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean D. Metcalfe, Cem Akin - The Journal of Allergy and Clinical Immunology In Practice 2022 被引用: 87

  10. Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 被引用: 478

  11. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

    著者: , , , , , , , , , , , , , , , , , - Nature Genetics 2010 被引用: 1,125

  12. Avapritinib versus Placebo in Indolent Systemic Mastocytosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrizia Bonadonna, Mark Rafferty, Nauman M. Butt, Stephen T. Oh, Friederike Wortmann, Johanna Ungerstedt, Mar Guilarte, Minakshi Taparia, Andrew Kuykendall, Cecilia Arana Yi, Princess U. Ogbogu, Caroline Gaudy‐Marqueste, Mattias Mattsson, William Shomali, Matthew P. Giannetti, Ilda Bidollari, Huimin Lin, Erin Sulllivan, Brenton G. Mar, Robyn M. Scherber, Maria Roche, Cem Akin, Marcus Maurer - NEJM Evidence 2023 被引用: 76

  13. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

    著者: , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2012 被引用: 761

  14. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2022 被引用: 70

  15. A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients with Myeloid/Lymphoid Neoplasms (MLNs) with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement (MLN FGFR1)

    著者: , , , , , , , , , , , - Blood 2021 被引用: 51

  16. Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 834

  17. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hans Hägglund, Wolfgang R. Sperr, Lawrence B. Schwartz, Massimo Triggiani, Marcus Maurer, Gunnar Nilsson, Hans‐Peter Horny, Michel Arock, Alberto Órfão, Dean D. Metcalfe, Cem Akin, Peter Valent - Journal of Allergy and Clinical Immunology 2015 被引用: 382

  18. Myeloid neoplasms with eosinophilia

    著者: , - Blood 2016 被引用: 275

  19. Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 被引用: 147

  20. International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vito Sabato, Agnes Bretterklieber, Dietger Niederwieser, Christine Breynaert, Karin Hartmann, Massimo Triggiani, Bogusław Nedoszytko, Andreas Reiter, Alberto Órfão, Olivier Hermine, Jason Gotlib, Michel Arock, Hanneke C. Kluin‐Nelemans, Peter Valent - The Lancet Haematology 2019 被引用: 138

  21. Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 104

  22. Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean D. Metcalfe, Peter Valent - The Journal of Allergy and Clinical Immunology In Practice 2021 被引用: 80

  23. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity

    著者: , , , , , , , - Seminars in Immunopathology 2021 被引用: 68

  24. Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2022 被引用: 51